Graphite Bio, Inc.
NASDAQ:GRPH
3.18 (USD) • At close March 21, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Assets: | |||||
Current Assets: | |||||
Cash & Cash Equivalents
| 185.861 | 47.73 | 376.976 | 19.782 | 0.006 |
Short Term Investments
| 0 | 220.499 | 0 | 0 | 0 |
Cash and Short Term Investments
| 185.861 | 268.229 | 376.976 | 19.782 | 0.006 |
Net Receivables
| 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 2.16 | 7.136 | 4.76 | 1.286 | 0 |
Total Current Assets
| 188.021 | 275.365 | 381.736 | 21.103 | 0.006 |
Non-Current Assets: | |||||
Property, Plant & Equipment, Net
| 0.321 | 28.21 | 18.081 | 1.461 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0.114 | 15.322 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0 | 3.005 | 2.17 | 0 | 0 |
Total Non-Current Assets
| 0.435 | 46.537 | 20.251 | 1.461 | 0 |
Total Assets
| 188.456 | 321.902 | 401.987 | 22.564 | 0.006 |
Liabilities & Equity: | |||||
Current Liabilities: | |||||
Account Payables
| 0.25 | 2.608 | 2.453 | 0.63 | 0 |
Short Term Debt
| 0.285 | 4.045 | 5.482 | 0 | 2.205 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 3.871 | 0 | 0 |
Other Current Liabilities
| 4.262 | 6.39 | 0.337 | 31.418 | 0.019 |
Total Current Liabilities
| 4.797 | 13.043 | 12.143 | 32.048 | 2.224 |
Non-Current Liabilities: | |||||
Long Term Debt
| 0.077 | 1.749 | 5.794 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| -0 | 10.819 | 0 | 55.924 | 0 |
Total Non-Current Liabilities
| 0.077 | 12.568 | 5.794 | 55.924 | 0 |
Total Liabilities
| 4.874 | 25.611 | 17.937 | 87.972 | 2.224 |
Equity: | |||||
Preferred Stock
| 0 | 0 | 401.987 | 55.608 | 0 |
Common Stock
| 0.001 | 0.001 | 0.001 | 0 | 0 |
Retained Earnings
| -367.054 | -242.403 | -141.351 | -70.591 | -2.218 |
Accumulated Other Comprehensive Income/Loss
| 0 | -1.048 | -401.987 | 0 | 0 |
Other Total Stockholders Equity
| 550.635 | 539.741 | 525.4 | -50.425 | 0 |
Total Shareholders Equity
| 183.582 | 296.291 | 384.05 | -65.408 | -2.218 |
Total Equity
| 183.582 | 296.291 | 384.05 | -65.408 | -2.218 |
Total Liabilities & Shareholders Equity
| 188.456 | 321.902 | 401.987 | 22.564 | 0.006 |